ATE501258T1 - Lawsonia intracellularis impfstoff - Google Patents
Lawsonia intracellularis impfstoffInfo
- Publication number
- ATE501258T1 ATE501258T1 AT05104073T AT05104073T ATE501258T1 AT E501258 T1 ATE501258 T1 AT E501258T1 AT 05104073 T AT05104073 T AT 05104073T AT 05104073 T AT05104073 T AT 05104073T AT E501258 T1 ATE501258 T1 AT E501258T1
- Authority
- AT
- Austria
- Prior art keywords
- relates
- lawsonia intracellularis
- nucleic acid
- detection
- dna
- Prior art date
Links
- 241001148567 Lawsonia intracellularis Species 0.000 title abstract 6
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 108020004414 DNA Proteins 0.000 abstract 3
- 108020004511 Recombinant DNA Proteins 0.000 abstract 2
- 239000000969 carrier Substances 0.000 abstract 2
- 238000001514 detection method Methods 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 150000007523 nucleic acids Chemical group 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00204660 | 2000-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE501258T1 true ATE501258T1 (de) | 2011-03-15 |
Family
ID=8172486
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01204919T ATE330013T1 (de) | 2000-12-20 | 2001-12-14 | Lawsonia intracellularis impfstoff |
| AT05104073T ATE501258T1 (de) | 2000-12-20 | 2001-12-14 | Lawsonia intracellularis impfstoff |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01204919T ATE330013T1 (de) | 2000-12-20 | 2001-12-14 | Lawsonia intracellularis impfstoff |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US6921536B2 (de) |
| EP (2) | EP1586646B1 (de) |
| JP (1) | JP4237960B2 (de) |
| AT (2) | ATE330013T1 (de) |
| AU (1) | AU783210B2 (de) |
| CA (1) | CA2365494A1 (de) |
| DE (2) | DE60120621T2 (de) |
| DK (2) | DK1586646T3 (de) |
| ES (2) | ES2360225T3 (de) |
| HU (1) | HUP0105379A3 (de) |
| PL (1) | PL205964B1 (de) |
| PT (1) | PT1219711E (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60120621T2 (de) * | 2000-12-20 | 2006-12-14 | Intervet International B. V. | Lawsonia intracellularis Impfstoff |
| JP4256341B2 (ja) | 2002-05-29 | 2009-04-22 | ヤマサ醤油株式会社 | 新規なポリリン酸：ａｍｐリン酸転移酵素 |
| US7662390B2 (en) | 2003-09-12 | 2010-02-16 | Intarvet International B.V. | Lawsonia intracellularis subunit vaccine |
| BRPI0507017A (pt) * | 2004-01-22 | 2007-06-05 | Intervet Int Bv | ácido nucleico que codifica uma proteìna de lawsonia intracellularis, fragmento de dna, molécula de dna recombinante, carreador recombinante vivo, célula hospedeira, proteìna de lawsonia intracellularis, uso da mesma, vacina para combater as infecções por lawsonia intracellularis, método para preparação da mesma, e, teste de diagnóstico |
| EP1609870A1 (de) * | 2004-06-24 | 2005-12-28 | Boehringer Ingelheim Vetmedica Gmbh | Methode, um Lawsonia intracellularis zu diagnostizieren |
| MY146476A (en) * | 2004-06-24 | 2012-08-15 | Boehringer Ingelheim Vetmed | Method of diagnosing lawsonia intracellularis |
| AU2005308583A1 (en) * | 2004-11-24 | 2006-06-01 | Pharmacia & Upjohn Company Llc | Methods for cultivating Lawsonia intracellularis |
| US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
| JP2008538502A (ja) * | 2005-04-18 | 2008-10-30 | ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド | サブユニットワクチン中の構成成分として有用なローソニアタンパク並びにその製造方法及び使用方法 |
| US8398994B2 (en) | 2005-07-15 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia vaccine and methods of use thereof |
| US8470336B2 (en) | 2006-05-25 | 2013-06-25 | Boehringer Ingelheim Vetmedica, Inc. | Vaccination of young animals against Lawsonia intracellularis infections |
| US20080241190A1 (en) * | 2006-11-13 | 2008-10-02 | Boehringer Ingelheim Vetmedica, Inc. | Vaccination of horses against lawsonia intracellularis |
| EP2859900A1 (de) | 2006-12-11 | 2015-04-15 | Boehringer Ingelheim Vetmedica, Inc. | Wirksames Verfahren zur Behandlung von Infektionen mit dem porcinen Circovirus und Lawsonia intracellularis |
| EP2200643B1 (de) | 2007-09-17 | 2013-09-04 | Boehringer Ingelheim Vetmedica, Inc. | Ein lawsonia intracellularis lebendimpfstoff verabreicht in kombination mit einem antibiotikum zur behandlung von lawsonia intracellularis infektionen in schweine |
| TWI449533B (zh) | 2008-04-18 | 2014-08-21 | Intervet Int Bv | 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗 |
| TWI551295B (zh) | 2008-04-18 | 2016-10-01 | 英特威特國際股份有限公司 | 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗 |
| ES2534556T3 (es) * | 2008-07-22 | 2015-04-24 | Intervet International Bv | Bacteria Lawsonia intracellularis de un nuevo serotipo, vacuna basada en esa bacteria, anticuerpos adecuados para diagnosticar el nuevo serotipo de Lawsonia intracellularis e hibridomas para producir dichos anticuerpos |
| KR101837768B1 (ko) | 2011-05-25 | 2018-03-12 | 건국대학교 산학협력단 | 돼지 증식성 회장염을 진단하기 위한 단백질 및 그 응용 |
| US20140017268A1 (en) * | 2012-06-05 | 2014-01-16 | Regents Of The University Of Minnesota | Composition and Methods for Detecting or Preventing Lawsonia intracellularis Infections |
| EP3253409B1 (de) | 2015-02-04 | 2020-05-06 | Intervet International B.V. | Impfstoff zur verwendung gegen subklinische lawsonia-infektion bei einem schwein |
| EP3253410B1 (de) | 2015-02-04 | 2020-05-06 | Intervet International B.V. | Impfstoff zur verwendung gegen subklinische lawsonia-infektion bei einem schwein |
| RU2771533C2 (ru) * | 2015-10-16 | 2022-05-05 | Канзас Стейт Юниверсити Рисерч Фаундейшн | Иммуногенные композиции для иммунизации свиней против цирковируса типа 3 и способы их получения и применения |
| CL2017002196A1 (es) | 2017-08-30 | 2017-11-17 | Univ De Concepción | Vacuna recombinante contra enteropatía proliferativa en animales. |
| CN113528683A (zh) * | 2021-07-09 | 2021-10-22 | 南京农业大学 | 一种用于检测胞内劳森菌的绝对荧光定量pcr引物对、试剂盒及检测方法 |
| CN120559226A (zh) * | 2025-06-26 | 2025-08-29 | 杭州缇牧生物科技有限公司 | 猪胞内劳森菌抗体检测试纸及其应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4310993A (en) | 1980-01-07 | 1982-01-19 | Louvers & Dampers, Inc. | Louver assembly |
| DE69101683T2 (de) | 1990-07-30 | 1994-07-21 | Akzo Nv | Rekombinantes Mareks-Krankheitsvirus. |
| WO1993004163A1 (en) | 1991-08-23 | 1993-03-04 | Massachusetts Institute Of Technology | Strain of chlamydia |
| US5610059A (en) * | 1992-11-09 | 1997-03-11 | University Of Arizona | Etiological agent for porcine enteritis |
| FR2714074B1 (fr) | 1993-12-20 | 1996-03-01 | Pasteur Institut | Promoteurs des gènes GRA1, GRA2, GRA5 et GRA6 de toxoplasma gondii et vecteurs d'expression comprenant lesdits promoteurs. |
| US5885823A (en) | 1995-06-05 | 1999-03-23 | Nobl Laboratories, Inc. | Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| US5714375A (en) * | 1995-06-05 | 1998-02-03 | Nobl Laboratories, Inc. | Ileal symbiont intracellularis propagation in suspended host cells |
| JP2000502054A (ja) * | 1995-11-30 | 2000-02-22 | アグリカルチャー ビクトリア サービシーズ ピーティーワイ．エルティーディー． | 治療用および診断用の組成物 |
| EP1177213A4 (de) | 1999-05-13 | 2002-08-28 | Pfizer Prod Inc | Von lawsonia stammendes gen und assoziierte hämolysin-polypeptide, peptide und proteine und ihre verwendungen |
| NZ515331A (en) | 1999-05-13 | 2003-07-25 | Pfizer Prod Inc | Lawsonia derived gene and related FlgE polypeptides, peptides and proteins and their uses |
| AU767390B2 (en) * | 1999-05-13 | 2003-11-06 | Agriculture Victoria Services Pty Ltd | (lawsonia) derived gene and related OmpH polypeptides, peptides and proteins and their uses |
| JP2003501013A (ja) | 1999-05-13 | 2003-01-14 | ファイザー プロダクツ インコーポレーティッド | ローソニア由来の遺伝子及び関連ＳｏｄＣポリペプチド、ぺプチド及びタンパク質並びにそれらの使用 |
| EP1094070A3 (de) | 1999-10-22 | 2002-01-09 | Pfizer Products Inc. | Lawsonia intracellularis Proteine sowie Methoden und Materialien die diese verwenden |
| US6605696B1 (en) * | 1999-10-22 | 2003-08-12 | Pfizer, Inc. | Lawsonia intracellularis proteins, and related methods and materials |
| DE60120621T2 (de) * | 2000-12-20 | 2006-12-14 | Intervet International B. V. | Lawsonia intracellularis Impfstoff |
-
2001
- 2001-12-14 DE DE60120621T patent/DE60120621T2/de not_active Expired - Lifetime
- 2001-12-14 EP EP05104073A patent/EP1586646B1/de not_active Expired - Lifetime
- 2001-12-14 DK DK05104073.1T patent/DK1586646T3/da active
- 2001-12-14 AT AT01204919T patent/ATE330013T1/de active
- 2001-12-14 DK DK01204919T patent/DK1219711T3/da active
- 2001-12-14 ES ES05104073T patent/ES2360225T3/es not_active Expired - Lifetime
- 2001-12-14 EP EP01204919A patent/EP1219711B1/de not_active Expired - Lifetime
- 2001-12-14 ES ES01204919T patent/ES2266090T3/es not_active Expired - Lifetime
- 2001-12-14 PT PT01204919T patent/PT1219711E/pt unknown
- 2001-12-14 AT AT05104073T patent/ATE501258T1/de not_active IP Right Cessation
- 2001-12-14 DE DE60144201T patent/DE60144201D1/de not_active Expired - Lifetime
- 2001-12-18 CA CA002365494A patent/CA2365494A1/en not_active Abandoned
- 2001-12-19 HU HU0105379A patent/HUP0105379A3/hu unknown
- 2001-12-19 PL PL351277A patent/PL205964B1/pl not_active IP Right Cessation
- 2001-12-19 JP JP2001385373A patent/JP4237960B2/ja not_active Expired - Fee Related
- 2001-12-20 US US10/034,500 patent/US6921536B2/en not_active Expired - Fee Related
- 2001-12-20 AU AU97371/01A patent/AU783210B2/en not_active Ceased
-
2005
- 2005-07-13 US US11/180,997 patent/US7491401B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1586646A2 (de) | 2005-10-19 |
| HUP0105379A3 (en) | 2004-07-28 |
| PL351277A1 (en) | 2002-07-01 |
| EP1219711A2 (de) | 2002-07-03 |
| JP4237960B2 (ja) | 2009-03-11 |
| US7491401B2 (en) | 2009-02-17 |
| ES2360225T3 (es) | 2011-06-02 |
| DK1219711T3 (da) | 2006-09-25 |
| US6921536B2 (en) | 2005-07-26 |
| ATE330013T1 (de) | 2006-07-15 |
| DE60120621T2 (de) | 2006-12-14 |
| DE60120621D1 (de) | 2006-07-27 |
| EP1219711B1 (de) | 2006-06-14 |
| PT1219711E (pt) | 2006-10-31 |
| US20050069559A1 (en) | 2005-03-31 |
| US20050250150A1 (en) | 2005-11-10 |
| HUP0105379A2 (hu) | 2003-01-28 |
| PL205964B1 (pl) | 2010-06-30 |
| DK1586646T3 (da) | 2011-06-27 |
| EP1586646B1 (de) | 2011-03-09 |
| CA2365494A1 (en) | 2002-06-20 |
| JP2003000276A (ja) | 2003-01-07 |
| EP1219711A3 (de) | 2002-11-06 |
| DE60144201D1 (de) | 2011-04-21 |
| ES2266090T3 (es) | 2007-03-01 |
| HU0105379D0 (en) | 2002-02-28 |
| AU9737101A (en) | 2002-06-27 |
| AU783210B2 (en) | 2005-10-06 |
| EP1586646A3 (de) | 2007-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE330013T1 (de) | Lawsonia intracellularis impfstoff | |
| ATE470673T1 (de) | Impfstoffe mit lawsoniaintrazellularis- untereinheit | |
| ATE479756T1 (de) | Streptococcus pneumoniae-antigene und impfstoffe | |
| DE60139690D1 (de) | Immunisierung gegen chlamydia pneumoniae | |
| ATE406912T1 (de) | Immunisierung gegen chlamydia tracheomatis | |
| DE60131858D1 (de) | Borrelia burgdorferi rekombinante genkonstrukte | |
| ATE450545T1 (de) | Impfstoff mit lawsonia intracellularis- untereinheit | |
| WO2003058248A3 (en) | Diagnostics and vaccines for mycrobacterium paratuberculosis infections | |
| WO2003095480A3 (en) | Brachyspira hyodysenteriae vaccine | |
| WO2004007726A3 (en) | Brachyspira hyodysenteriae vaccine | |
| WO2004020609A3 (en) | Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection | |
| ATE417106T1 (de) | Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon | |
| ATE366583T1 (de) | Identifizierung von spezifischen differenziell exprimierten antigenen aus mycobacterium und medizinische verwendung der mycobakteriumproteine rv0068 und rv3407 | |
| NO20081541L (no) | Ny sjo-lus vaksine | |
| DK1664097T3 (da) | Piroplasmidvaccine | |
| PT1176192E (pt) | Vacina de helicobacter felis | |
| WO2004024769A3 (en) | Ostertagia vaccine | |
| DE60229966D1 (de) | Diabetesmodell | |
| WO2000006739A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |